Duration: (18:15) ?Subscribe5835 2025-02-24T01:15:25+00:00
Time to Significant Benefit of Finerenone in Patients with Heart Failure | JACC | HFSA 2024
(7:6)
Part 2: Time to Significant Benefit of Finerenone in Patients With Heart Failure | JACC | HFSA 2024
(11:17)
Finerenone in Patients With Recent Worsening Heart Failure Event: The FINEARTS-HF Trial | HFSA 2024
(18:15)
ESC 2022: FIDELITY: Finerenone in Pts With Chronic Kidney Disease | Prof Gerasimos Filippatos
(5:45)
NEJM at ESC — Finerenone in Heart Failure for Mildly Reduced or Preserved Ejection Fraction
(3:28)
ESC 24: FINE-HEART: Finerenone in HF \u0026 CKD
(4:25)
Finerenone... adding life to years in Kidney Disease
(4:59)
Cardiovascular Outcomes With Finerenone in Patients With CKD and Diabetes
(4:27)
Finerenone Insights
(13:10)
FIGARO-DKD Trial Results
(4:44)
HFSA 24: Finerenone Across the Ejection Fraction Spectrum: FINEARTS-HF
(6:46)
ESC 24 Hot Line Discussion: The FINEARTS-HF Trial
(17:29)
Treatment With Finerenone In Chronic Kidney Disease | N5
(16:19)
Finerenone in Patients with Diabetes and CKD
(29:23)
Finerenone Medication Review
(9:)
So, what is finerenone, anyway?
(10:34)
Finerenone Investor-Webinar
(56:20)
Ep. 05 What's new: Finerenone as a Treatment for Diabetic Kidney Disease
(2:17)
FIGARO: Where will finerenone fit into diabetic kidney disease treatment | David Wheeler
(7:22)
Fineronone
(8:11)